Lewitt and colleagues (2024) reviewed the role of IGFBP-1 in cardiovascular disease, emphasizing its involvement in cellular growth, signaling, and metabolic regulation—pathways central to angiogenesis, atherosclerosis, and thrombosis [15]. This evidence concerns the gene IGFBP1 and atherosclerosis.